Candel Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Candel Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q2 2024.
  • Candel Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 32.1M shares, a 10.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 32.1M +3.16M +10.9% Aug 5, 2024 10-Q 2024-08-13
Q1 2024 29.3M +428K +1.48% Mar 21, 2024 10-K/A 2024-04-25
Q3 2023 28.9M +25.8K +0.09% Nov 1, 2023 10-Q 2023-11-09
Q2 2023 28.9M +27.9K +0.1% Aug 2, 2023 10-Q 2023-08-10
Q1 2023 28.9M +229K +0.8% Mar 15, 2023 10-K/A 2023-05-01
Q3 2022 28.9M +204K +0.71% Nov 2, 2022 10-Q 2022-11-10
Q2 2022 28.9M Jul 31, 2022 10-Q 2022-08-05
Q1 2022 28.7M Mar 15, 2022 10-K 2022-03-29
Q3 2021 28.7M Aug 31, 2021 10-Q 2021-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.